Ku-Geng Huo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ku-Geng Huo

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Bioengineering & Translational Medicine|March 10, 2025

Unleashing the potential of mRNA: Overcoming delivery challenges with nanoparticlesQiang Chen, Ku-Geng Huo, Sheng-Min Ji, et al.

Cardiovascular Research|October 11, 2017

Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injuryTlili Barhoumi, Julio C Fraulob-Aquino, Muhammad Oneeb Rehman Mian, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021

Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase InhibitorsKu-Geng Huo, Hirotsugu Notsuda, Zhenhao Fang, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Bioengineering & Translational Medicine|March 10, 2025

Unleashing the potential of mRNA: Overcoming delivery challenges with nanoparticlesQiang Chen, Ku-Geng Huo, Sheng-Min Ji, et al.

Cardiovascular Research|October 11, 2017

Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injuryTlili Barhoumi, Julio C Fraulob-Aquino, Muhammad Oneeb Rehman Mian, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021

Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase InhibitorsKu-Geng Huo, Hirotsugu Notsuda, Zhenhao Fang, et al.

Pageof 2